Cargando…

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

BACKGROUND: Although a number of serum biomarkers for detection of hepatocellular carcinoma (HCC) have been explored, their exact diagnostic value remains unclear. We aimed to conduct a direct comparison of five representative serum biomarkers for detecting HCC and to derive multi-marker prediction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hongda, Zhang, Yue, Li, Siwen, Li, Ni, Chen, Yuhan, Zhang, Bei, Qu, Chunfeng, Ding, Huiguo, Huang, Jian, Dai, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044429/ https://www.ncbi.nlm.nih.gov/pubmed/30022853 http://dx.doi.org/10.2147/CMAR.S167036

Ejemplares similares

Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
por: Gao, Rong, et al.
Publicado: (2015)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

GPC-3 in hepatocellular carcinoma: current perspectives
por: Wu, Yongle, et al.
Publicado: (2016)

Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway
por: Wang, Shanshan S, et al.
Publicado: (2017)

A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection
por: Dumstrei, Karin, et al.
Publicado: (2016)

Serum hsa_circ_0000615 is a prognostic biomarker of sorafenib resistance in hepatocellular carcinoma
por: Zhang, Lunjun, et al.
Publicado: (2022)

Five Critical Gene-Based Biomarkers With Optimal Performance for Hepatocellular Carcinoma
por: Liu, Yongjun, et al.
Publicado: (2023)

Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer
por: Chen, Hongda, et al.
Publicado: (2017)

GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation
por: Ding, Hongda, et al.
Publicado: (2020)

Serum AFU, 5’-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis
por: Junna, Zhu, et al.
Publicado: (2017)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma
por: Li, Xiaojin, et al.
Publicado: (2021)

Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2016)

Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
por: Kim, Seung Up, et al.
Publicado: (2015)

Hepatocellular Carcinoma Surveillance and Treatment: A Way to Reduce Cancer-related Mortality in Cirrhotic Patients
por: Qian, Xiangjun, et al.
Publicado: (2019)

Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma
por: Zheng, Xiaoqin, et al.
Publicado: (2021)

Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma
por: Chen, Shuying, et al.
Publicado: (2022)

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021)

Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study
por: Chen, Yangqin, et al.
Publicado: (2017)

Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis
por: Wang, Chong, et al.
Publicado: (2015)

Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells
por: Wang, Shanshan, et al.
Publicado: (2021)

Serum Metabolites as Potential Biomarkers for Diagnosis of Knee Osteoarthritis
por: Zhang, Qingmeng, et al.
Publicado: (2015)

Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma
por: Song, Ting, et al.
Publicado: (2021)

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013)

Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study
por: Liu, Dongming, et al.
Publicado: (2021)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
por: Qi, Peng, et al.
Publicado: (2011)

Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2022)

Serum-Derived Exosomal Proteins as Potential Candidate Biomarkers for Hepatocellular Carcinoma
por: Zhao, Liping, et al.
Publicado: (2021)

Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2019)

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
por: Zhang, Zhu-qing, et al.
Publicado: (2014)

Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
por: Wu, Jianxiong, et al.
Publicado: (2012)

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma
por: Chauhan, Ranjit, et al.
Publicado: (2016)

Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
por: Lu, Yonghai, et al.
Publicado: (2017)

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection
por: Ye, Fei, et al.
Publicado: (2021)

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
por: Zhang, Laizhu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pajih8rstea6dlr186v2190etc